載入...
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
Nomegestrol acetate (NOMAC) 2.5 mg with 17-beta estradiol (E2) 1.5 mg is a new combined oral contraceptive (COC) formulation and is the first monophasic E2 pill to be marketed, having been licensed for use in Europe in 2011. It is available to be taken daily in a regimen of 24 active pills followed...
Na minha lista:
| 發表在: | Open Access J Contracept |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683186/ https://ncbi.nlm.nih.gov/pubmed/29386925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OAJC.S61942 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|